All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 2012-12-10? to Wed 2025-08-06 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
VOO × |
+6.03%
2025-08-06 |
5.114 TRR
2025-08-06 |
||||
Vanguard S&P 500 ETF Exchange-Traded Fund | ||||||
ABBV × |
+10.77%
2025-08-06 |
6.656 TRR
2025-08-06 |
||||
AbbVie Inc NYSE Common Stock | ||||||
Mon 2012-12-10? to Wed 2025-08-06 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
VOO × |
+299.70%
+11.57%/yr |
+10.00%/yr
(R2=0.951) |
||||
Vanguard S&P 500 ETF Exchange-Traded Fund | ||||||
ABBV × |
+565.65%
+16.16%/yr |
+14.30%/yr
(R2=0.942) |
||||
AbbVie Inc NYSE Common Stock | ||||||
Mon 2012-12-10? to Wed 2025-08-06 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
VOO × |
$10,000.00
2012-12-10 |
$39,969.76
2025-08-06 |
||||
Vanguard S&P 500 ETF Exchange-Traded Fund | ||||||
ABBV × |
$10,000.00
2012-12-10 |
$66,564.94
2025-08-06 |
||||
AbbVie Inc NYSE Common Stock | ||||||
Year | VOO | ABBV |
---|---|---|
2025 (YTD) | +6.03% | +10.77% |
2024 | +21.48% | +15.54% |
2023 | +22.23% | −3.46% |
2022 | −23.15% | +16.47% |
2021 | +20.33% | +23.73% |
2020 | +16.73% | +26.00% |
2019 | +28.43% | −0.79% |
2018 | −6.28% | −2.81% |
2017 | +19.25% | +56.75% |
2016 | +9.90% | +7.56% |
2015 | +0.58% | −7.17% |
2014 | +12.71% | +26.95% |
2013 | +30.43% | +58.39% |
2012 | +14.02% | −2.20% |
2011 | −1.04% | — |
2010 | +14.34% | — |
Mon 2012-12-10? to Wed 2025-08-06 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
VOO × | −0.76% |
−33.95%
2020-03-23 |
||||
Vanguard S&P 500 ETF Exchange-Traded Fund | ||||||
ABBV × | −8.94% |
−47.00%
2019-08-15 |
||||
AbbVie Inc NYSE Common Stock | ||||||